FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064832 [Registered on: 27/03/2024] Trial Registered Prospectively
Last Modified On: 21/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Relationship of serum LDH With fetomaternal outcome in pre eclampsia 
Scientific Title of Study   Association of serum lactate dehydrogenase with fetomaternal outcome in pre eclampsia- A cross sectional study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr KHUSHBOO CHAURASIA 
Designation  JUNIOR RESIDENT 
Affiliation  ROHILKHAND MEDICAL COLLEGE AND HOSPITAL 
Address  ROOM NO 1178, Department of OBG, ROHILKHAND MEDICAL COLLEGE AND HOSPITAL, PILIBHIT BYPASS ROAD, BAREILLY

Bareilly
UTTAR PRADESH
243006
India 
Phone  09755686239  
Fax    
Email  khushboochaurasia25@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR LATA AGRAWAL 
Designation  PROFESSOR 
Affiliation  ROHILKHAND MEDICAL COLLEGE AND HOSPITAL 
Address  ROHILKHAND MEDICAL COLLEGE AND HOSPITAL, PILIBHIT BYPASS ROAD, BAREILLY

Bareilly
UTTAR PRADESH
243006
India 
Phone  9557033100  
Fax    
Email  drlataagrawal.la@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR KHUSHBOO CHAURASIA 
Designation  JUNIOR RESIDENT 
Affiliation  ROHILKHAND MEDICAL COLLEGE AND HOSPITAL 
Address  ROOM NO 1178, Department of OBG ROHILKHAND MEDICAL COLLEGE AND HOSPITAL, PILIBHIT BYPASS ROAD, BAREILLY

Bareilly
UTTAR PRADESH
243006
India 
Phone  09755686239  
Fax    
Email  khushboochaurasia25@gmail.com  
 
Source of Monetary or Material Support  
Rohilkhand medical college and hospital 
 
Primary Sponsor  
Name  Department of obstetric and gynaecology 
Address  ROHILKHAND MEDICAL COLLEGE AND HOSPITAL, PILIBHIT BYPASS ROAD, BAREILLY 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Khushboo Chaurasia  ROHILKHAND MEDICAL COLLEGE AND HOSPITAL  ROHILKHAND MEDICAL COLLEGE AND HOSPITAL, PILIBHIT BYPASS ROAD, BAREILLY
Bareilly
UTTAR PRADESH 
9755686239

khushboochaurasia25@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, RMCH, Bareilly, U.P.  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O149||Unspecified pre-eclampsia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1.Singelton pregnancy.
2.Pregnant women at more than 28 weeks of period till term of gestation.
3.Women willing for our participation as per protocol.
 
 
ExclusionCriteria 
Details  1.Patient with history of diabetes, renal disease, chronic hypertension, liver disease, chronic lung disease, connective tissue disorders, seizure, DIC, stroke, smoking, alcoholism, any hepatotoxic drugs, thyroid disorder and UTI.
2.Patient with molar pregnancy, gestational diabetes mellitus. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Relationship of LDH in pre eclampsia  1 year 
 
Secondary Outcome  
Outcome  TimePoints 
Maternal mortality, morbidity and fetal outcome  1 year 
 
Target Sample Size   Total Sample Size="147"
Sample Size from India="147" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   07/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Preeclampsia is described as a pregnancy specific syndrome that can affect every organ system of the body. It is defined as new onset hypertension and either proteinuria or other signs of end organ damage after 20 weeks of gestation in a previously normotensive normoproteinuric woman. It involves multisystem disorder which includes thrombocytopenia, renal dysfunction, hepatocellular necrosis, central nervous system pertubations or pulmonary oedema. It is a syndrome where mother and fetus both are affected.

Maternal syndrome includes hypertension, intra uterine growth retardation, oliguria, HELLP syndrome, seizure, oedema, proteinuria, pleural effusion, pulmonary oedema, thrombocytopenia, disseminated intravascular coagulation and hemoconcentration.

Fetal syndrome includes preterm delivery, intra uterine fetal death.

Young and nulliparous are more vulnerable to develop preeclampsia while older women have a greater risk for developing chronic hypertension with superimposed preeclampsia. It is well proven that it is primarily a disorder of first pregnancy.

Gestational hypertension is a transient hypertension which develops after 20 weeks of gestation in a previously normotensive women with no proteinuria or no signs of endorgan damage.

Preeclampsia when complicated with Grand Mal Seizures (Generalized Tonic Clonic convulsions) and/or coma is called Eclampsia.

The American College of Obstetricians and Gynaecologists describes four types of hypertensive diseases:

1.     Preeclampsia and eclampsia syndrome

2.     Chronic hypertension due to other causes

3.     Preeclampsia superimposed on chronic hypertension

4.     Gestational hypertension

In normal pregnancy there is invasion of the endovascular trophoblasts into the wall of the spiral arterioles of the uteroplacental bed.Endovascular trophoblasts invades up to decidual segments in the first trimester(10-12 wks) and another wave of trophoblasts invades up to the myometrial segments in second trimester (16-18 wks), thus the endothelial lining and muscular arterial walls is replaced by fibrinoid formation as a result spiral arterioles becomes torturous,distended and funnel shaped which in turn transforms the spiral arterioles into a low resistance, low pressure, high flow system.In Preeclampsia there is a failure of second wave of endovascular trophoblast migration and reduction of blood supply to the fetoplacental unit.There are many theories which explain the pathophysiology of preeclampsia.One of the accepted hypothesis is abnormal placentation with incomplete secondary wave of trophoblastic invasion which leads to reduced uteroplacental blood flow, placental ischaemia and hypoxia.

Preeclampsia is seen in 5-8% of all pregnancies. It can virtually affect every organ system.It can be divided into early onset i.e., <34 wks; late onset i.e., >= 34 wks; Preterm onset i.e., <37 wks; Term onset i.e., >=37 wks.

Lactate Dehydrogenase is a marker which is raised in Preeclampsia. Its levels are several times higher inside the cell as compared to plasma. It is an intracellular enzyme belongs to 2-hydroxy acid oxidoreductase group which is responsible for interconversion of Pyruvate and Lactate in the cells during Glycolysis which is the major energy pathway in the placenta. In preeclampsia there is cell damage which results in leakage of enzyme into the circulation causing high serum levels.


 
Close